Table 1.

Baseline characteristics of 77 patients with metastatic prostate cancer

Characteristicsn (% or IQR)
Age, y70 (63-77)
Prostate-specific antigen at diagnosis (ng/mL)21.1 (7.7-95.1)
Initial treatment
    Radical prostatectomy24 (31)
    Radiation therapy to the prostate16 (21)
    No treatment37 (48)
Sites of metastasis
    Bone only25 (33)
    Lymph node and bone31 (40)
    Lymph node only6 (8)
    Visceral disease14 (18)
    Bone and soft tissue (other than lymph node)1 (1)
CTC counts per 7.5 mL blood, median (IQR)29 (7-89)
Prostate-specific antigen (ng/mL), median (IQR)188.2 (65.9-573.4)
FISH probeNo. patient samples hybridizedNo. (%) patients with FISH results
AR only1313 (100)
AR + MYC1511 (73)
MYC + 8p2318 (78)
AR + MYC + 8p2625 (96)
Total7767 (87)